Maruho Co., Ltd.

27 clinical trials · Sponsor

Record	Firm	Date
An Open-label, Phase 2 Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Systemic Sclerosis (NCT05214794)	Maruho Co., Ltd.	2022-04-20
A Phase 2, Multicenter, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pefcalcitol Ointment, 0.005%, Applied Topically Twice Daily (BID) for 8 Weeks in Adolescent Subjects 12 to < 17 Years of Age With Plaque Psoriasis (NCT02970331)	Maruho Co., Ltd.	2019-06-01
Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis (NCT03688971)	Maruho Co., Ltd.	2018-10-22
Topical Ionic Contra-Viral Therapy in Actinic Keratosis (NCT03684772)	Maruho Co., Ltd.	2018-10-22
A Study to Evaluate the Safety and Efficacy of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts (NCT03259620)	Maruho Co., Ltd.	2017-10-30
ICVT in HPV-induced Genital Lesions of Immunocompromised and Immunocompetent Patients (NCT03334240)	Maruho Co., Ltd.	2017-10-05

Every clearance here is in the API, with alerts when new ones post.